Biocon to react sharp on good Q2 numbers
DSIJ Intelligence / 21 Oct 2016
Biotechnology giant, Biocon post markets hours on October 21 has declared its Q2FY17 results. The results were expected to be positive. In Q2, the company has posted a net profit of Rs 146.7 crores. In Q2FY16, it had posted a net loss of Rs 10.6 crores.
Biotechnology giant, Biocon post markets hours on October 21 has declared its Q2FY17 results. The results were expected to be positive. In Q2, the company has posted a net profit of Rs 146.7 crores. In Q2FY16, it had posted a net loss of Rs 10.6 crores. Total income from operations stands at Rs 954.1 crores, which has increased by 20 per cent as compared to the corresponding quarter of the previous fiscal.
The small molecules division which includes Active Pharma Ingredients (API) stands at Rs 389 crores and has grown by 15 per cent YoY. Good sales numbers from Latin America and Africa and Middle East regions were the major reason for such a positive result. The stocks of the company are expected to react sharp. The scrip in the last 3 months has given a return of 40 per cent. Fifty-two-week High/low stands at Rs 1010/430.80.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.